DDX59-AS1 is a prognostic biomarker and correlated with immune infiltrates in OSCC

DDX59-AS1 is a prognostic biomarker and correlated with immune infiltrates in OSCC

Background: lncRNAs play a critical role in multiple steps of gene regulation associated with tumor progression. However, the engagement of DDX59-AS1, a lncRNA, remains equivocal, particularly in oral squamous cell carcinoma (OSCC). In this study, the expression of DDX59-AS1 and its association with...

Full description

Bibliographic Details
Main Authors:	Yang Sun, Qianrong Zhou, Jian Sun, Wei Bi, Ruixue Li, Xingwen Wu, Ni Li, Liang Song, Fei Yang, Youcheng Yu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Genetics
Subjects:	OSCC TCGA biomarker immune infiltrates DDX59-AS1
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.892727/full

Similar Items

Deciphering the potential ability of DExD/H-box helicase 60 (DDX60) on the proliferation, diagnostic and prognostic biomarker in pancreatic cancer: a research based on silico, RNA-seq and molecular biology experiment
by: Dongdong Zhang, et al.
Published: (2025-01-01)

LRRC59 promotes the progression of oral squamous cell carcinoma by interacting with SRP pathway components and enhancing the secretion of CKAP4-containing exosomes
by: Qijun Sun, et al.
Published: (2024-03-01)

DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression
by: Kun Xu, et al.
Published: (2022-08-01)

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types
by: Ankang Hu, et al.
Published: (2022-11-01)

miR-617 interacts with the promoter of DDX27 and positively regulates its expression: implications for cancer therapeutics
by: Neelanjana Sarkar, et al.
Published: (2024-06-01)

Corrigendum: DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression
by: Kun Xu, et al.
Published: (2023-06-01)

CENPA acts as a prognostic factor that relates to immune infiltrates in gliomas
by: Bo Wang, et al.
Published: (2022-10-01)

The Function, Role and Process of DDX58 in Heart Failure and Human Cancers
by: Ping Yu, et al.
Published: (2022-06-01)

Expression of DDX5 and DDX17 in ovarian cancer tissues and their effects on proliferation and drug resistance of human ovarian cancer cell line SKOV3
by: HUANG Jie, LI Runbo, GUO Jianxin, HAN Jian
Published: (2023-08-01)

Pan-cancer analysis identifies DDX56 as a prognostic biomarker associated with immune infiltration and drug sensitivity
by: Zhaohui Ruan, et al.
Published: (2022-12-01)

GABRP is a Promising Prognostic Biomarker and Associated with Immune Cell Infiltration in Lung Squamous Cell Carcinoma
by: Fu J, et al.
Published: (2023-04-01)

mRNA-seq-based analysis predicts: AEG-1 is a therapeutic target and immunotherapy biomarker for pan-cancer, including OSCC
by: Lihong Yao, et al.
Published: (2024-10-01)

ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma
by: Shuochen Liu, et al.
Published: (2023-05-01)

Systematic analysis of virus nucleic acid sensor DDX58 in malignant tumor
by: Zhijian Huang, et al.
Published: (2022-12-01)

XPO1 serves as a prognostic marker involving AKT/MAPK/TGFBR1 pathway in OSCC
by: Ying Han, et al.
Published: (2024-08-01)

TYK2 correlates with immune infiltration: A prognostic marker for head and neck squamous cell carcinoma
by: Yaodong He, et al.
Published: (2022-12-01)

Identification of therapeutically potential targets and their ligands for the treatment of OSCC
by: Pratima Kumari, et al.
Published: (2022-09-01)

Single-minded homolog 2 as a potential prognostic signature and assessment of its correlation with immune cell infiltration in pancreatic cancer
by: Qian Hu, et al.
Published: (2024-02-01)

Metabolomics and metagenomics reveal the impact of γδ T inhibition on gut microbiota and metabolism in periodontitis-promoting OSCC
by: Wei Wei, et al.
Published: (2024-02-01)

HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis
by: Mei-Ling Dong, et al.
Published: (2022-06-01)

ANXA9 as a novel prognostic biomarker associated with immune infiltrates in gastric cancer
by: Tongtong Zhang, et al.
Published: (2021-12-01)

DAPK enhances DDX20 protein stability via suppression of TRIM25-mediated ubiquitination-based DDX20 degradation
by: Yan Ye, et al.
Published: (2024-11-01)

Exosomal cargoes in OSCC: current findings and potential functions
by: Chengzhi Zhao, et al.
Published: (2020-11-01)

TMEM200A is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer
by: Fujin Fang, et al.
Published: (2023-06-01)

Prognostic value and immune-infiltration pattern of FOXD3-AS1 in patients with glioma
by: Zhenhua Chen, et al.
Published: (2023-04-01)

Prognostic and immune infiltration significance of ARID1A in TCGA molecular subtypes of gastric adenocarcinoma
by: Zhenkun Zhang, et al.
Published: (2023-08-01)

FAT1 Upregulates in Oral Squamous Cell Carcinoma and Promotes Cell Proliferation via Cell Cycle and DNA Repair
by: Ting Lan, et al.
Published: (2022-05-01)

Prognostic significance of the rho GTPase RHOV and its role in tumor immune cell infiltration: a comprehensive pan‐cancer analysis
by: Qin Qin, et al.
Published: (2023-11-01)

Combination therapy with venetoclax and azacitidine for the treatment of myelodysplastic syndromes with DDX41 mutations
by: Xin Wang, et al.
Published: (2024-12-01)

Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer
by: Tian-Hao Li, et al.
Published: (2022-09-01)

Correlation of histopathological patterns of OSCC patients with tumor site and habits
by: Madiha Muhammad Yasin, et al.
Published: (2022-07-01)

Pan-cancer analysis of the prognostic and immunological roles of DEAD-box helicase 5 (DDX5) in human tumors
by: Shixuan Liu, et al.
Published: (2022-10-01)

Removal of HCH and DDX from historical polluted soils by zerovalent iron technology
by: Mihai Stefanescu, et al.
Published: (2024-07-01)

The Role of the RNA Helicase DDX3X in Medulloblastoma Progression
by: Akanksha Swarup, et al.
Published: (2024-07-01)

Overexpression of DDX49 in prostate cancer is associated with poor prognosis
by: Junyue Tao, et al.
Published: (2023-04-01)

BANF1 is a novel prognostic biomarker linked to immune infiltration in head and neck squamous cell carcinoma
by: Yaodong He, et al.
Published: (2024-10-01)

Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma
by: Juan Fang, et al.
Published: (2017-05-01)

Gene microarray analysis revealed a potential crucial gene RACK1 in oral squamous cell carcinoma (OSCC)
by: Jian-Wei Zheng, et al.
Published: (2018-03-01)

PRRSV hijacks DDX3X protein and induces ferroptosis to facilitate viral replication
by: Qian Mao, et al.
Published: (2024-08-01)

Integrative analysis of lysine acetylation-related genes and identification of a novel prognostic model for oral squamous cell carcinoma
by: Shi-Zhou Deng, et al.
Published: (2023-08-01)